The US Food and Drug Administration approved Picato (ingenol mebutate) gel, (0.015%, 0.05%) for the topical treatment of the precancerous condition, actinic keratosis. Manufactured by Leo Pharma, Parsippany, New Jersey, Picato gel is reported to be the first and only topical actinic keratosis therapy that can be used for as little as 2 or 3 days.

[black up pointing small triangle] Information: http://www.leo-pharma.us